Parithera SA

Parithera enables accurate treatment decision guidance & monitoring from one simple blood draw

An alternative to tissue biopsy is to study cells which detach from the solid tumors and find access to the blood stream. The so-called circulating tumor cells (CTCs) are retrieved via Liquid Biopsy. Parithera ExTrace enables clinicians to monitor treatment response and choose the best therapy based on single cell RNA (scRNA) sequencing data.

Parithera’s innovative approach is based on two inventions in the domain of CTC isolation and sequencing preparation.